Targacept: What's Left After Latest TC-5214 Disappointment?
Dec 20, 2011 | Posted by: roboblogger | Full story: Seeking Alpha
Today AstraZeneca and Targacept announced the results from their second of four Phase 3 trials for TC-5214, a depression drug.
|AstraZeneca Submits sNDA for Seroquel XR for th... (May '08)||Sep '13||Damion||2|
|AstraZeneca, Merck collaborate on cancer treatment (Jun '09)||Sep '13||Jasper||2|
|AstraZeneca (Dec '07)||Sep '13||Todd||2|
|AstraZeneca Submits sNDA for SEROQUEL® for B... (Apr '06)||Sep '13||Brian||5|
|AstraZeneca Announces New Program that Offers S... (Nov '06)||Sep '13||Constance||11|
|Inspector highlights psych drug use among elderly (Nov '11)||Aug '13||Jones||2|
|Inspector Highlights Psych Drug Use Among Elderly (Dec '11)||Aug '13||Miln||3|